Verastem Obtains $32,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e47831cf-50e8-4c81-8a33-843dd08286dc&Preview=1 -
Date
7/14/2011 -
Company Name
Verastem -
Mailing Address
215 First Street Cambridge, MA 02142 -
Company Description
Verastem, Inc. is a private biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. -
Website
http://www.Verastem.com -
Transaction Type
Venture Equity -
Transaction Amount
$32,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. -
M&A Terms
-
Venture Investor
Advanced Technology Ventures -
Venture Investor
Astellas Venture Management -
Venture Investor
Longwood Founders Fund -
Venture Investor
Longwood Founders Fund -
Venture Investor
Bessemer Venture Partners -
Venture Investor
MPM Capital -
Venture Investor
Cardinal Partners
